North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

Clinical trial NCT01408030 · COMPLETED

Trial details

NCT number: NCT01408030
Sponsor: James Gossage
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Telangiectasia, Hereditary Hemorrhagic Epistaxis

Start date: 2011-08-01
Primary completion: 2014-09-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.